PMV Pharmaceuticals, Inc. — Director's Dealing 2022

Apr 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2022-04-20

Reporting Person: Kung Winston (COO, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-20	Common Stock	M	4000	$3.22	Acquired	10600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-04-20	Stock Option (right to buy)	$3.22	M	4000	Disposed	2028-02-21	Common Stock (4000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.22	2028-02-21	Common Stock (237412)	237412	Indirect

Footnotes

F1: The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant.

F2: All of the shares subject to the option are vested and immediately exercisable.

F3: The shares are held of record by the Winston Kung Irrevocable Family Trust for the benefit of the reporting person's immediate family.